Kymera Therapeutics (KYMR) Shares Outstanding (Diluted) (2020 - 2026)
Kymera Therapeutics' Shares Outstanding (Diluted) came in at 98.18 million for Q2 2026, up 22.0% from 80.45 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Kymera Therapeutics (KYMR) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, Kymera Therapeutics' Shares Outstanding (Diluted) was 84.49 million, up 12.6% from FY2024.
- Shares Outstanding (Diluted) has increased in each of the last five years, with a five-year compound annual growth rate of 37.2% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 75.04 million in FY2024 (+28.6%), 58.37 million in FY2023 (+8.2%), 53.93 million in FY2022 (+12.4%) and 47.99 million in FY2021 (+176.6%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2020.
- Year-over-year, Shares Outstanding (Diluted) has increased for 19 consecutive quarters, with growth averaging 19.2% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 7.1% in Q3 2023 to 197.7% in Q1 2022.
- Business Quant data shows KYMR's Shares Outstanding (Diluted) at 97.53 million (Q1 2026), 84.49 million (Q4 2025) and 87.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Kymera Therapeutics | 9.12 Bn | 6.42 Bn | - | 98.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 98.18 Mn |
| Mar 31, 2026 | 97.53 Mn |
| Dec 31, 2025 | 84.49 Mn |
| Sep 30, 2025 | 87.30 Mn |
| Jun 30, 2025 | 80.45 Mn |
| Mar 31, 2025 | 80.15 Mn |
| Dec 31, 2024 | 75.04 Mn |
| Sep 30, 2024 | 76.13 Mn |
| Jun 30, 2024 | 73.06 Mn |
| Mar 31, 2024 | 70.77 Mn |
| Dec 31, 2023 | 58.37 Mn |
| Sep 30, 2023 | 58.42 Mn |
| Jun 30, 2023 | 58.33 Mn |
| Mar 31, 2023 | 58.19 Mn |
| Dec 31, 2022 | 53.93 Mn |
| Sep 30, 2022 | 54.54 Mn |
| Jun 30, 2022 | 51.77 Mn |
| Mar 31, 2022 | 51.65 Mn |
| Dec 31, 2021 | 47.99 Mn |
| Sep 30, 2021 | 50.71 Mn |
API Access
Kymera Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KYMR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();